Catch up on the top radiology content of the past week.
|Articles|July 9, 1997
Trex taps executives for divisions
Danbury, CT-based Trex Medical has named new presidents for its Lorad and Continental X-Ray divisions. Taking over as president of Lorad is John Brenna, former vice president of marketing for Trex Medical. Brenna assumed Lorad's presidency from Hal
Advertisement
Danbury, CT-based Trex Medical has named new presidents for its Lorad and Continental X-Ray divisions. Taking over as president of Lorad is John Brenna, former vice president of marketing for Trex Medical. Brenna assumed Lorad's presidency from Hal Kirshner, who gave up the post to focus on his role as president and CEO for Trex Medical. Kirshner retains his CEO title for Lorad.
In Trex's Continental X-Ray division, Patrick Fitzgerald III has been promoted to president. Fitzgerald, who had previously served as director of national accounts for Trex Medical, succeeds his father, Patrick Fitzgerald II, who is retiring.
In other Trex news, director of international sales John Mankowich has joined Trex competitor Gendex as vice president and general manager.
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: September 27 — October 3
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
3
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
4
Emerging Research Insights and New Advances in Neuroradiology
5